SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193805-18-000567
Filing Date
2018-04-23
Accepted
2018-04-23 16:40:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 e617939_sc13da-at.htm SC 13D/A 26070
2 e617939_ex-h.htm EX-99.H 9702
  Complete submission text file 0001193805-18-000567.txt   37132
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87471 | Film No.: 18769271
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Filed by) CIK: 0001727315 (see all company filings)

Type: SC 13D/A